Tyler Dylan-Hyde Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Tyler Dylan-Hyde.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Tyler Dylan-Hyde. Tyler Dylan-Hyde is a Chief Legal Officer in CRISPR Therapeutics AG ($CRSP).
Address: C/O CRISPR THERAPEUTICS, INC. 200 SIDNEY ST. CAMBRIDGE 02139 MA
Companies in which Tyler Dylan-Hyde is an Insider
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Tyler Dylan-Hyde: Chief Legal Officer
Holdings: 25,204 shares
Current Value: $396,963
Latest Transaction: Jan 18 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Tyler Dylan-Hyde
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Option Exercise | M | 12.57 | 19,890 | 250,017 | 5,237 | |
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Option Exercise | M | 12.57 | 1,110 | 13,953 | 36,663 | |
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Sell | S | 28.10 | 19,890 | 558,909 | 25,204 | 45.1 K to 25.2 K (-44.11 %) |
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Buy | M | 12.57 | 19,890 | 250,017 | 45,094 | 25.2 K to 45.1 K (+78.92 %) |
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Sell | S | 28.24 | 1,110 | 31,346 | 25,204 | 26.3 K to 25.2 K (-4.22 %) |
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Buy | M | 12.57 | 1,110 | 13,953 | 26,314 | 25.2 K to 26.3 K (+4.40 %) |
| Jan 18 2018 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Sell | S | 28.00 | 45,000 | 1,260,000 | 25,204 | 70.2 K to 25.2 K (-64.10 %) |